Back

Prognostic value of baseline lactate levels in patients with infarct-related cardiogenic shock with and without ECLS therapy- a substudy of the ECLS-SHOCK trial

21 March 2026 (12:00 - 13:00)
Organised by: Logo
Congress Presentation Part of: Deep dive in cardiac arrest Cardiogenic Shock ACVC Premium Access ESC Acute CardioVascular Care 2026 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Anna Juliane Buch

Heart Center Leipzig at University of Leipzig, Leipzig (Germany)

7 More presentations in this session

Presentation thumbnail
Door to lactate clearance: insights from a randomized trial in out of hospital cardiac arrest
Doctor R. Paulin Beske (Copenhagen, DK)
Abstract
Presentation thumbnail
Rhythm-specific associations between low-flow time and short-term outcomes after out-of-hospital cardiac arrest (OHCA)
Miss A. Low (Singapore, SG)
Abstract
Presentation thumbnail
Assessment of left and right ventricular function in out-of-hospital cardiac arrest
Doctor S. Schneekloth (Copenhagen, DK)
Abstract
Presentation thumbnail
The association between ventilator parameters in the initial 48h and outcomes after out-of-hospital cardiac arrest. A sub-study of the TAME trial.
Doctor M. Baumann Melberg (Oslo, NO)
Abstract
Presentation thumbnail
Outcomes after OHCA: insights into survival, neurological function, and quality of life
Doctor S. Esteves (Lisbon, PT)
Abstract

Access the full session

Session thumbnail
Deep dive in cardiac arrest

The Event

Event poster

ESC Acute CardioVascular Care 2026

21 March 2026 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of arterial lactate on admission in patients with infarct-related cardiogenic shock: is there a difference between patients with and without pre-hospital cardiac arrest ?
thumbnail
Congress Presentation
Lactate clearance as a prognostic marker in cardiogenic shock: a retrospective study from a tertiary cardiac intensive care unit
thumbnail
Congress Presentation
Prognostic value of different lactate metrics in patients treated with peripheral veno-arterial extracorporeal membrane oxygenation (VA-ECMO)

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources